Skip to main content
Article
Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy.
Journal of Clinical Oncology (2013)
  • Alex Cruz
  • Dung-Tsa Chen, University of South Florida
  • William J. Fulp, University of South Florida
  • Michael Chuong
  • Sarah Hoffe, University of South Florida
  • Ravi Shridhar, University of South Florida
  • Nikhil G Rao
  • Pamela Joy Hodul, Loyola University Chicago
  • Mokenge Peter Malafa, University of Florida
  • Nicholas Figura, University of South Florida
  • Edward Eikman, University of South Florida
  • Gregory M. Springett, Massachusetts Institute of Technology
Publication Date
January 2, 2013
DOI
10.1200/jco.2013.31.4_suppl.310
Citation Information
Alex Cruz, Dung-Tsa Chen, William J. Fulp, Michael Chuong, et al.. "Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy." Journal of Clinical Oncology Vol. 31 (2013) p. 310 - 310
Available at: http://works.bepress.com/michael-chuong/14/